We think differently about mental health so you can too

Our vision is a world of mental wellbeing.

COMPASS is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first programme is researching how investigational COMP360 psilocybin treatment (also known as psilocybin therapy) could help people with treatment-resistant depression.

We want to transform the patient experience in mental health care.

More about us

Watch this video to learn more about our work

Our team

Everyone has a mental health story, be it their own, or that of a friend or loved one. Our people bring their stories, and a wide range of backgrounds and skills to COMPASS.

Meet the team

Kabir Nath Chief Executive Officer

We all have immediate family members, friends or colleagues who are struggling with serious mental illness and the scale is devastating – that’s why I'm determi...

Anne Benedict Chief People Officer

We have a unique opportunity here at COMPASS to make a remarkable impact on humanity by improving the lives of so many people. That’s a purpose that is so meaning...

Chris Williams Chief Communications Officer

I am excited to join COMPASS and its talented and purpose-driven team. As one of the innumerable people around the world whose life has been touched by mental illne...

Greg Ryslik Chief Technology Officer

At COMPASS, we're in the unique position to combine therapies, technology and data to help some of the most vulnerable people in our society and work to transform t...

Dr Guy Goodwin Chief Medical Officer

I was offered a once in a lifetime opportunity to change the direction for patient care in psychiatry. Only COMPASS can do it - what a moment to join the party.

Matt Owens General Counsel and Chief Legal Officer

COMPASS is bringing innovation to mental health care, and I am so excited to join them. I am passionate about digital health and improving the patient experience an...

Mike Falvey Chief Financial Officer

I am excited to be joining COMPASS Pathways during such a pivotal time in our development. We have the opportunity to create an entirely new avenue of treatment to...

Trevor Mill Chief Development Officer

I joined COMPASS Pathways to help advance innovation in mental health drug development, and to accelerate much needed treatment access for patients suffering from d...

Our research

Our research is evidence-based and underpinned by a commitment to find better ways to support and empower people suffering with poor mental health.

Discover more

News & views

Our collective understanding of mental health is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology, and digital platforms.

View all news & views

Please note that we are not able to diagnose, advise, provide acute or chronic care, or make treatment referrals. If you need urgent help, please contact the emergency services or your doctor as soon as possible.

We receive many enquiries from people wishing to participate in our phase 3 programme of COMP360 psilocybin treatment for treatment-resistant depression, and our phase 2 trials in post-traumatic stress disorder and anorexia nervosa.

To find out whether you may be eligible to take part in our phase 3 programme of COMP360 psilocybin treatment for treatment-resistant depression, please click here.

To find out more about our phase 2 trial of COMP360 psilocybin treatment for post-traumatic stress disorder, please click here.

To find out more about our phase 2 trial of COMP360 psilocybin treatment for anorexia nervosa, please click here.

For media enquiries, contact us at media@compasspathways.com.